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APPENDIX 1
MEDTECH: A Simulation Model of an Emerging New Medical Technology
Introduction
The purpose of this appendix is to present a more detailed
view of the medical technology simulation model discussed in the body
of the paper. This is not intended to be a comprehensive description
of the computer model, MEDTECH, which contains approximately 100
active equations. Instead, the discussion will focus on only the most
important relationships in the model, occasionally presenting them in
equation form. We hope that this approach to model description will
satisfy those who desire a "closer look" at the model.
The MEDTECH model is a deterministic system of difference
equations. The equations are of three general types: level, rate,
and auxiliary equations. Level (or state) equations are of the form:
where L^ is the value of the level L at time t, dt is the time
interval used for computation of changes, and R^_^^ is the value of
the rate R from time t-dt to time t. The computation interval dt is
chosen to be quite small relative to other time constants in the model
so that model behavior will approximate closely the continuous
behavior of a corresponding system of differential equations.
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Changes in levels are produced by rate equations, which are
instantaneous functions of level and/or auxiliary variables. If a
level L is expressed in "units" (e.g., people), then its associated
rate R is expressed in "units per time period" (people per year).
Auxiliary equations are also instantaneous functions of level
and/or other auxiliary variables, and should be thought of as
intermediate concepts which link levels to rates. In the MEDTECH
model, these auxiliary concepts—such as the concept of "average
effectiveness"—account for about half of the equations, with level
and rate variables splitting the other half about evenly. Auxiliary
variables help to make explicit the modeler's notions of how decision-
makers in the system perceive and process the information available to
them.
The structural relationships and parameter values in the
MEDTECH model were drawn from a variety of numerical, written, and
anecdotal information sources. In order to develop a general model
applicable to a variety of medical technologies, we made extensive use
of theoretical and empirical literature on the diffusion of
innovations, particularly in the medical field. This literature was
most helpful on the topic of opinion formation. Many of the
relationships in MEDTECH were based on discussions with experts and
other parties familiar with specific pieces of the overall system.
Discussions with physicians, government policy analysts and
evaluators, and company representatives involved in promotional
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marketing and technical development, exposed us to a large number of
issues and facts which were necessary for the construction of a
comprehensive and objective model of emerging medical technologies.
These discussions served as an invaluable "reality check" throughout
the development of the model.
All three kinds of information mentioned above were useful in
specifying the MEDTECH model to the case of PICA. The primary source
of numerical data was the PTCA registry, which contains detailed
information regarding the usage and effectiveness of the procedure on
a center-by-center basis. Written information included journal
articles and the published proceedings from an NIH-sponsored
conference on PTCA held in 1979. Anecdotal information on PTCA was
obtained from NIH-associated physicians and administrators and from
representatives of USCI, the leading manufacturer of PTCA equipment.
A comprehensive catalog of relationships, assumptions, and data used
in modeling PTCA is presently being prepared.
The MEDTECH model consists of five interconnected subsystems,
which will be discussed in detail below with examples drawn from the
case of PTCA. These subsystems are: Usage (U), Patient Selection
Criteria (PSC), Opinion Formation (OF), Evaluation (E), and Technical
Development (TD). Each subsystem makes use of information which may
originate from v;ithin the subsystem, from other subsystems, or from
outside the entire system. The description of each subsystem is
accompanied by a subsystem diagram using symbols explained in the key
below (Figure 1-1). These subsystem diagrams show, in a somewhat
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Fisure 1-1. A Key to the Subsystem Diap;.rr»ms
A level (state, stock, accumulation) variable
^ -^
A rate (event, flo'v, change) variable
An information link
f
The parameter "P" is exogenous (determined
outside the entire system as modeled)
p
f
The parameter "P" is determined in another
subsystem
W-^ 1
The information affects another subsystem "3"
A decision or activity function
A non-decision function
A delay or lag structure:
"T" is the delay time
'"N" is the name of the delay (optional)
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simplified form, the important variables and relationships in the
MEDTECH model. A "decision function" consists of one or more
auxiliary or level variables leading to the indicated action. A
"non-decision function", by contrast, always consists of a single
auxiliary variable. A delay structure consists of a series of levels
and rates which produces a lag between input and output information.
Usage Subsystem (Figure 1-2)
The Usage subsystem is responsible for generating the demand
and supply of procedures and their average effectiveness, as well as
practitioners and their degree of expertise. Procedures are measured
on a flow basis; for example, 1,000 PTCA's per year. Average effec-
tiveness is a relative measure of the true benefit-to-cost ratio of
the technique, as it is used by the average practitioner. If there
were no benefits, effectiveness would equal zero. If the benefit-to-
cost ratio were equal to the existing standard or goal, the effec-
tiveness would equal 1, by definition. Thus, effectiveness will take
on values greater than 1 when the standard for effectiveness is
exceeded by the average practitioner. Practitioners are physicians
who have the know-how, the materials and equipment, the staff, and the
time required to perform procedures on a regular basis. Practitioners
are assumed to have a certain maximum capacity to perform procedures
(e.g., 50 procedures per year per practitioner, in the PTCA model),
and a certain normal or desired utilization level of that capacity
A-
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(two-thirds, in the PICA model). Experience is defined as the proce-
dures performed in the past which impinge directly on a practitioner's
skill.
The demand for the procedure is computed as a product of
three terms determined outside the usage subsystem, adjusted by a term
which reflects recent availability of the procedure. The availability
factor represents the idea that if a patient has to wait for months or
must fly across the country to receive the procedure, his physician
will be less likely to recoinnend it than if no such difficulties
existed. This decision, of course, depends on the availability of
alternative procedures, the urgency of the patient's condition, and
other factors. Assuming there is no shortage of procedures, however,
the following equation for demand obtains:
Demand for procedure = (Reference patient flow) (convinced MD
fraction) ( selection criteria).
This equation can be understood best by way of example. For
PTCA, the reference patient flow is assumed to be the 100,000 or so
coronary bypass graft candidates per year from whom PTCA recipients
are selected. The convinced MD fraction represents that fraction of
physicians v*io would recommend PTCA instead of CABG to those patients
who match the selection criteria. Suppose this fraction were ^0%;
also suppose that the selection criteria were such that PTCA was
indicated for 5% of all CABG candidates. Then our equation shows
that:
Demand for PTCA = (100,000 patients/year) (. 10) ( .05)
= 500 patients/year
A-
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An increased demand for procedures produces two responses in
the model. The first is to increase the utilization of existing
capacity so that more procedures can be performed with the existing
practitioners. In concrete terms, this means increasing the workload
of the average practitioner, resulting in longer hours worked or in
the undesirable displacement of some other portion of his practice.
The second response to increased demand is to bring more practitioners
on-line. The "practitioner start-up rate" refers to the whole process
of perceiving the demand, becoming trained, and obtaining the
materials, equipment, and staff required to be a practitioner. A
policy which restricts the technology primarily affects practitioner
start-up, making it more difficult or less advantageous to enter
practice than if the restrictions did not apply.
As procedures are performed, practitioners gain experience
which can improve their effectiveness. The "sum of experience" level
indicates the total amount of relevant experience over all
practitioners. One way in which such experience can be lost is
through a natural process of depreciation or decay over time. In
other words, since a procedure done yesterday is of greater benefit to
one's skill than a procedure done last year, the experience value of
having done a procedure must diminish over time. This process of
experience depreciation may become important during periods of low
demand. The second way in which the sum of experience may decrease is
by "drop-out": when a practitioner decides to quit the practice, he
takes along a certain level of experience. If that level is greater
than the average experience of practitioners, then the whole field may
be left worse off than before his departure.
The determination of average effectiveness requires two
stages. First, we look at the effectiveness with which the technology
is being applied by fully-skilled practitioners. This is assumed to
be a function of the ratio of the selection criteria to the technol-
ogy's present technical capability. If the selection criteria are
broad relative to the technique's true capability, skilled
effectiveness will be low. Relatively narrow criteria can produce
higher effectiveness, but only up to a point. Criteria and capability
are both expressed as fractions of the reference patient flow; in the
baseline PTCA model, we assumed that criteria were initially 9%, while
capability was initially 6% of CABG candidates. Technical capability
is defined such that when the criteria match the capability, the
resulting skilled effectiveness equals 1. The skilled effectiveness
function used in the case of PTCA is shown below in Figure 1-3.
Average effectiveness can now be determined by multiplying
skilled effectiveness by an experience or "learning curve" effect.
The learning curve is s monotonically increasing function of the
average experience per practitioner. Different technologies will have
different learning curves, of course, but in general, the curve
becomes essentially flat as experience increases. In the case of
PTCA, for example, there appears to be a significantly greater
difference in skill between a ten-procedure practitioner and a twenty-
procedure practitioner than between a thirty-procedure practitioner
and a forty-procedure practitioner.
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Figure 1-3. Skilled Effectiveness (SKE) as a Function
of the Ratio of Selection Criteria (SO to
Technical Capability (TO.
Patient Selection Criteria Subsystem (Figure 1-^)
The Patient Selection Criteria subsystem generates the
breadth of selection criteria, that is, the fraction of the reference
patient flow considered to be candidates for the procedure. There are
two factors that motivate change of the criteria. First, as
practitioners adopt new technical modifications, they will tend to
expand the criteria to include those patients for whom the modifica-
tions appear to make effective application possible. For instance,
PTCA catheters are now being produced with new shapes that enable the
practitioner to dilate lesions that were unreachable or produced
problems in the past. Second, evaluations that reveal that the
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technique's effectiveness is lower than desired will cause practi-
tioners to become more selective in their choice of patients; that is,
they will narrow the selection criteria in order to improve outcomes.
Similarly, relatively high levels of evaluated effectiveness may
encourage some broadening of criteria. The degree to which
evaluations produce change in the selection criteria is affected by
the characteristics of practitioners. When practitioners are few in
number, that may imply much greater flexibility of criteria and a
greater willingness to experiment with changes than when there are
many practitioners. Depending on the field in question, of course,
increasing numbers of practitioners may result in significantly more
conservatism and less innovativeness
.
The change in selection criteria originating from evaluted
effectiveness is assumed to take place on a fraction-per-year basis;
that is, change in criteria = (criteria) (fractional change per year).
Figure 1-5 shows the relationship between evaluated effectiveness and
the fractional change in selection criteria assumed in the baseline
PTCA model, under conditions of maximum flexibility (relatively few
practitioners)
.
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Figure 1-5. Fractional Change in Selection Criteria
from Evaluation (FCSCEV) as a Function of
Evaluated Effectiveness (EVE).
Opinion Formation Subsystem (Figure 1-6)
The Opinion Formation subsystem generates the Convinced MD
Fraction (CMDF), which is that fraction of the physicians of
reference patients v*io screen or consider their patients for the new
procedure. Each physician is considered to be in one of three
conditions: unknowledgeable (or unaware) of the technology;
knowledgeable but not convinced; or knowledgeable and convinced. CMDF
is the fraction of physicians in the third group. By definition,
then, CMDF is equal to the product of the knowledgeable M.D. fraction
(KMDF) and the convinced fraction of these knowledgeables (CFKMD);
that is, CMDF = (KMDF) (CFKMD)
.
Awareness-knowledge may be gained from three different
sources: colleague discussions, evaluative reports, and promotional
marketing by manufacturers. This process of learning is seen as an
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active one, in contrast to the process of forgetting, which will cause
awareness-knowledge to decay away naturally over time in the absence
of continued learning. Colleague discussions become more likely to
produce learning as the ratio of the knowledgeable to the
unknowledgeable increases. Evaluative reports and promotional mar-
keting can both perform teaching functions, but become marginally less
potent as they are increased. Both professional and conmercial media
may encounter such "saturation" effects because of limited audiences
and redundant or duplicated efforts.
The story is a similar one for the process of gaining
conviction, or acceptance, which also may be based on discussions with
colleagues, evaluations, and promotional marketing. In assessing
evaluative data, physicians are concerned with both quantity and
content: Evaluations will have their greatest persuasive effect when
they both carry numerical weight and when they reveal high
effectiveness. The degree to which physicians believe that the data
carry weight is assumed to be related to the evaluators' own assess-
ment of data sufficiency (the evaluative data fraction) and reflects
the relative enthusiasm or confidence (versus skepticism or caution)
of physicians concerning the new technology. Figure 1-7 shows the
relationship between the evaluative data fraction and the "weight of
evaluations for acceptance" used in the baseline PTCA model. Note
that the curve lies entirely above the 45 line, demonstrating our
assumption that physicians are relatively confident about the
technology's ultimate value.
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WEVA
Figure 1-7. Weight of Evaluations for Acceptance (WEVA)
as a Function of the Evaluative Data
Fraction (EVDF)
.
The process of losing conviction, or rejection of the
technology, is assumed to depend on evaluated effectiveness. If
evaluations start to demonstrate low effectiveness, the rate of
rejection may become quite high.
The decision to undertake promotional marketing is depicted
in the model as a response by manufacturers to what they perceive as
not enough procedures being done. Competition between manufacturers
plays no role in the model, so promotion is interpreted as manufac-
turer efforts to increase total usage through the teaching and persua-
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sion of physicians. The manufacturers' target number of procedures is
assumed to be the product of the reference patient flow and the
selection criteria the manufacturer believes to be supported by
available evidence. Promotional marketing will tend to increase when
a gap opens between this target and the actual supply of procedures.
Evaluation Subsystem (Figure 1-8)
The Evaluation subsystem generates evaluative reports and
data that reflect the technology's effectiveness. A central feature
of the evaluation process is the time required to collect and analyze
follow-up data on patients. Obviously, the longer this evaluation
completion time is, the greater the likelihood that evaluations
reflect past rather than present effectiveness of a dynamic new
technology.
Evaluations are undertaken in response to a gap between the
goal for evaluative data and the present level of evaluative data.
(The "evaluative data fraction", discussed in the previous section, is
simply the ratio of evaluative data to the goal for data; both are
expressed in numbers of patient-records.) However, if the number of
procedures being done is small, this may constrain evaluation starts.
If the problem is not with the number of procedures being done, but
rather with the number being reported, a voluntary registry may serve
to increase the number of cases under evaluation.
Procedure
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i!V'iluPtions in
Prot^ress
Evaluation
Completion
rilato
A-18
Selection
Criteria
/ \
/^ilvaluative",
/ Data '>
oum of
ii^valuated
"^f f ec tiven'jGK
~!f fectivi-
neat,
Figure 1-3. ZVALUATIOT: (y) Su^SYSHAV.
A-19
The goal for evaluative data responds to the breadth of
selection criteria and the evaluated effectiveness. As the criteria
expand, there will be a greater need for data to support the practice.
For example, if practitioners were to suddenly start using PICA for a
larger class of patients— say, for dilation of non-discrete
atheromatous lesions—then more data would be required to substantiate
the new applications. If the evaluated effectiveness is less than 1,
this indicates there is a need to become more selective in the choice
of patients, and consequently a need to evaluate the technique more
intensively. Conversely, if the evaluated effectiveness is quite high
and outcomes fairly certain, the requirement for data will be lower
than when the situation is uncertain.
The frequency of evaluative reports (which affects the
learning process) is assumed to be a function of both evaluations in
progress and the existing quantity of evaluative data. Public
statements regarding new findings occur not only because of the sheer
number of such findings, but also because of their relative contribu-
tion to the existing data base. In the case of PICA, for example,
there was a flurry of reports, including a press conference, all
within a couple years of the first procedure and during a time when
the technique was considered experimental. In the model, this signif-
icance or novelty effect is represented as a function of the ratio of
evaluations in progress to evaluative data, as shown in Figure 1-9.
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Figure 1-9. Effect of Significance on Evaluation Reports (ESEVR)
as a Function of the Ratio of Evaluations in Progress
(EVIP) to Evaluative Data (EVD).
(Subscript of "n" indicates normal or equilibrium value).
By definition, evaluated effectiveness is computed by
dividing the sum over all evaluative data of effectiveness (SEVE) by
the amount of evaluative data (EVD). Associated with each
patient-record is an indication of how that record will appear after
the evaluation is completed. A "perfect" evaluation technique would
be one for which the Indication of Evaluated Effectiveness is exactly
equal to the true effectiveness. A less comprehensive or careful
analysis might err on the optimistic side, thus encouraging greater
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use of the technique than is actually warranted. In fact, overuse of
the technology in the long term can only occur (in the model, at
least) if evaluations consistently overestimate effectiveness. This
may explain much of the current interest in randomized clinical
trials, which occasionally reveal problems with a technique that
non-randomized evaluations miss.
Technical Development Subsystem (Figure 1-10)
The Technical Development subsystem generates modifications
to the original innovation v*iich may increase its capability for
effective application. Technical modifications may be thought of as
manufacturer-created, although that is not necessarily the case.
Demand for modifications—that is, the set of ideas or suggestions
that motivates a manufacturer's development effort— is assumed to come
from practitioners, who are in the position to recognize potential
improvements, based on their experience and innovativeness, evaluative
data, and the success of previous modifications. The leading manufac-
turer of PTCA equipment estimates that at least 90% of their modifica-
tions have originated with practitioner suggestions.
Technical capability is increased by the technical
development rate. Neither of these quantities can be directly
measured by the medical community but must be inferred by trial-and-
error and careful evaluation. The technical development rate is
simply the product of technical modifications and the technical
development fraction, which is the degree to which a modification
A-22
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increases technical capability. The technical development fraction
will decrease as technical capability increases. This means that
there will be diminishing returns to modification as the technique
matures. In the model, the technical development fraction is a
function of the ratio of technical capability to "mature technical
capability", a parameter which is indicative of the technology's true
potential. In the baseline PTCA model, the mature technical capabil-
ity was assumed to be .2, or 20% of all CABG candidates. As Figure
1-11 shows, our definition of maturity is such that when technical
capability equals mature technical capability, the technical
development fraction (TDF) is 1/20th of its maximum or "normal" value
(TDFN). In general, TDF = (TDFN) (Effect of Technical Maturity on Development)
ETMD
1
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After a period of time required to try out the new
modifications, practitioners get an impression of their marginal
contribution to technical capability; this is the perceived technical
development fraction. Just as the true amount of development is the
product of modifications and the technical development fraction, the
perceived development rate is the product of modifications and the
perceived technical development fraction. The lag between actual and
perceived development fractions implies that practitioners may
seriously overestimate the significance of new modifications, based on
the success of previous ones, if the actual development fraction is
declining rapidly.
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APPENDIX 2
Behavior of the MEDTECH Model under Alternative Assumptions
and Policies
Introduction
The purpose of this appendix is to provide a more detailed analysis
of the results reported in the main body of the paper. These results
consist of two parts. First, we examine more closely the behavioral
elements that distinguish the "successful" pattern of usage from the
"unsuccessful" pattern. Second, we display and discuss briefly the cumu-
lative impacts of the four policy options under each of the two basic
usage patterns.
"Successful" and "Unsuccessful" Patterns of Usage
The plotted output data presented here compare various aspects of the
"successful" and "unsuccessful" patterns over ten years of usage, starting
from the first clinical application at time 0. The "baseline" policy option
of no regulations and no registry was assumed in both cases, for the pur-
pose of easy comparison.
Figure 2-1 shows procedure demand and supply for the two cases, plotted
on the same vertical scale of "procedures per year". Supply adjusts quickly
to demand in both cases, because of the relatively short practitioner start-
up time (1 year) . Plotted alongside the "successful" usage pattern, the
"unsuccessful" appears relatively insignificant. Its significance will
become apparent, however, when the curves for effectiveness are examined.
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The primary determinants of demand for the procedure (other than the
exogenous reference patient flow) are the convinced M.D. fraction and the
patient selection criteria. Figure 2-2 shows the changing Convinced M.D.
Fraction (CMDF) for the two cases. In the "successful" case, CMDF rises
quickly and exceeds 90% by year 5. The rapid growth in knowledge and
conviction seen here is triggered primarily by a burst of evaluative
activity producing favorable evidence after an average follow-up time of
only two years. In the "unsuccessful" case, CMDF reaches a peak of less
than 40% in year 5 and then drops off smoothly. The initial growth in
conviction is largely due to the appearance of high effectiveness in the
short term. VThen evaluations are completed (after an average follow-up
time of six years), however, the bad news of low effectiveness causes
conviction to shrink immediately.
Figure 2-3 includes plots of selection criteria and technical capa-
bility for both scenarios, with a vertical scale running from to 20%
of the reference flow of CABG candidates. In the "successful" case,
the criteria narrow for the first four years because of evaluations
indicating lower- than-desired effectiveness. As evaluated effectiveness
increases, there is less need to become more selective. Furthermore, the
accelerating increase in technical capability fuels expansion of the selec-
tion criteria, which actually surpass the true capability by year 10. In
the "unsuccessful" case, the selection criteria remain much higher than
the actual technical capability for most of the simulation, because of a
deceptively high initial appearance of effectiveness. As the evidence of
A-28
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low effectiveness starts to accumulate, however, the criteria narrow and
meet the true capability by year 10.
Figure 2-4 plots both average (actual) and evaluated (apparent)
effectiveness for the two scenarios. In the "successful" case, average
effectiveness climbs steadily for the first 2.5 years, reflecting
increasing selectivity of criteria. However, as the field starts to
grow and the average skill level drops, effectiveness also declines some-
what. By year 10, average effectiveness has fairly well stabilized at a
high level and will continue to climb slowly toward the goal of 1.0 as
practitioner experience increases and patient selection becomes even more
refined. Evaluated effectiveness in the "successful" scenario is essen-
tially a smoothed version of actual effectiveness and shows improved
outcomes, especially during the first four years of narrowing criteria.
The outstanding feature in the "unsuccessful" scenario is an initial
level of evaluated effectiveness which is far too optimistic. As evidence
accumulates, evaluated effectiveness drops to reflect past values of actual
effectiveness. Average effectiveness itself climbs from year 3 onward,
because of the closing gap between selection criteria and technical capa-
bility. However, the procedure has become discredited by the end of the
simulation, and it will require at least several more years for the medi-
cal community to realize that outcomes have improved significantly.
Figure 2-5 plots the effect of experience on effectiveness— the
"learning curve" effect— for the two scenarios. We assume that the ini-
tial applications of the technique are performed by highly skilled prac-
titioners who were involved in pre-clinical research and who have a good
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understanding of the mechanical or chemical principles involved. The
initial decline in average experience in both plots reflects the influx
of inexperienced practitioners that occurs during a period of growth in
demand. In the "successful" case, the trough in average practitioner
experience is reached by year 4. As the growth rate declines and the pool
of practitioners becomes more stable, average skill climbs back toward its
initial high level. In the "unsuccessful" case, a similar decline-and-
rise pattern of experience occurs but is follox^7ed by still another decline.
This secondary decline is produced not by growth in demand, but rather,
by lower utilization of capacity and an outflow of experienced practitioners
as the practice loses popularity. Thus, there can be problems of inexper-
ience associated both with rapid growth and rapid decline.
Cumulative Impacts of Alternative Policies
Tables 2-1 and 2-2 display the cumulative impacts of the four policy
options, under the assumptions used to produce the "successful" and
"unsuccessful" baseline cases, respectively. These impacts are measured
along three important dimensions; namely, the quantity of procedures,
their actual effectiveness, and the developed capability of the technique.
"Cumulative Average Effectiveness" is simply the average over all of the
procedures done to date ("Cumulative Procedures") of actual (average)
effectiveness. Technical capability is by its very nature a cumulative
variable and reflects the total contribution of technical modifications
to date.
Table 2-1 shows clearly the delay imposed by a regulatory policy
on the processes of dissemination (see "cumulative procedures") and
development ("technical capability") for a "successful" technology.
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Initially, this delay serves to increase average effectiveness of the
procedure by limiting its use to more skilled practitioners. However,
as the restrictions are lifted, the supply of practitioners increases
quickly and experience declines, compensating fully for the initial gains
in effectiveness. Regulatory restrictions, in this case, delay not only
adoption of the practice but also the establishment of stable criteria
that are appropriate to the practice's true potential. However, these
effects appear to be relatively small in magnitude and are of a transi-
tory nature only.
For a "successful" technology, the registry policy, implemented
either by itself or together with regulatory restrictions, appears to
increase the number of procedures done while it decreases their effect-
iveness by a small margin in the short term. The registry spurs earlier
use of the technique and therefore slightly more rapid development, but
with lower average practitioner experience. The magnitudes of change are
even smaller than for the regulatory policy, probably an indication that
the dynamics of supply and demand (affected by regulation) are more
important than those of evaluation (affected by the registry), in the
case of a "successful" technology.
Table 2-2 demonstrates the ability of the regulatory mechanism to
decrease usage and increase effectiveness, in the case of an "unsuc-
cessful" technology. The beneficial effect of the restrictions appears
to be greatest in the second half of the simulation (years 5-10), since
the detrimental effects of quickly falling demand on average practitioner
experience (see previous subsection) are largely avoided.
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As in the "successful" scenario, a voluntary registry for an "unsuc-
cessful" technology may have the effect of boosting usage by generating
greater knowledge and interest among physicians. When this policy is
implemented without accompanying regulatory restrictions, the result is
a steeper decline in the practice after year 5 and so lower experience
and effectiveness during the latter half of the simulation. However,
when the registry is used in combination with restrictions, the problem
of early overuse does not occur and effectiveness appears to be unaffected
or possibly improved (see the "+" sign in Table 2-2) . Once again, the
impact of the registry under our assumptions turns out to be quite small
in magnitude^ rendering our conclusions relative to this policy ambiguous
at best.



